Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-07 Sale |
2021-06-09 8:37 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $35 | $227,500 | 179,656 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-09 8:35 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $35 | $787,500 | 100,413 (Direct) |
View |
| 2021-03-30 Sale(A) |
2021-06-09 8:33 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $35 | $787,500 | 122,913 (Direct) |
View |
| 2021-04-26 Sale |
2021-04-28 9:15 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $35 | $227,500 | 186,156 (Direct) |
View |
| 2021-04-16 Sale |
2021-04-20 7:08 pm |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A See Remarks |
56,324 | $32.36 | $1,822,645 | 77,241 (Direct) |
View |
| 2021-03-30 Sale |
2021-04-01 7:37 pm |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $35 | $787,500 | 107,043 (Direct) |
View |
| 2021-01-28 Sale |
2021-01-29 9:00 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
5,000 | $55.05 | $275,250 | 176,786 (Direct) |
View |
| 2021-01-12 Sale |
2021-01-14 8:44 pm |
Relay Therapeutics Inc. | RLAY | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC STARR KEVIN P TEPPER ROBERT I LEVIN MARK J Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
5,622,394 | $40.4 | $227,132,712 | 7,739,918 (Indirect Direct) |
View |
| 2020-07-20 Purchase |
2020-07-21 7:20 pm |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
25,000 | $20 | $500,000 | 1,360,431 (Indirect Direct) |
View |
| 2020-07-20 Purchase |
2020-07-21 7:19 pm |
Relay Therapeutics Inc. | RLAY | Murcko Mark Director |
25,000 | $20 | $500,000 | 1,021,952 (Direct) |
View |
| 2020-07-20 Purchase |
2020-07-21 7:17 pm |
Relay Therapeutics Inc. | RLAY | Rubin Jami Director |
25,000 | $20 | $500,000 | 25,000 (Direct) |
View |
| 2020-07-20 Purchase |
2020-07-21 7:15 pm |
Relay Therapeutics Inc. | RLAY | INGRAM DOUGLAS S Director |
25,000 | $20 | $500,000 | 25,000 (Direct) |
View |
| 2020-07-20 Purchase |
2020-07-21 7:15 pm |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
10,000 | $20 | $200,000 | 10,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-07 Exercise |
2021-06-09 8:37 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $4.12 | 179,656 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 8:37 pm |
N/A 2028-03-22 |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $0 | 179,656 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 8:35 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $4.12 | 100,413 (Direct) |
View |
| 2021-06-07 Exercise |
2021-06-09 8:35 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $0 | 100,413 (Direct) |
View |
| 2021-03-30 Exercise(A) |
2021-06-09 8:33 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $4.12 | 122,913 (Direct) |
View |
| 2021-03-30 Exercise(A) |
2021-06-09 8:33 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $0 | 122,913 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-21 7:46 pm |
N/A 2031-05-18 |
Relay Therapeutics Inc. | RLAY | Shawver Laura Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-21 7:45 pm |
N/A 2031-05-18 |
Relay Therapeutics Inc. | RLAY | Rubin Jami Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-21 7:44 pm |
N/A 2031-05-18 |
Relay Therapeutics Inc. | RLAY | Murcko Mark Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-21 7:43 pm |
N/A 2031-05-18 |
Relay Therapeutics Inc. | RLAY | Borisy Alexis Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-21 7:42 pm |
N/A 2031-05-18 |
Relay Therapeutics Inc. | RLAY | INGRAM DOUGLAS S Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-21 7:40 pm |
N/A 2031-05-18 |
Relay Therapeutics Inc. | RLAY | HILL LINDA A Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-04-26 Exercise |
2021-04-28 9:15 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $4.12 | 186,156 (Direct) |
View |
| 2021-04-26 Exercise |
2021-04-28 9:15 pm |
N/A 2028-03-22 |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
6,500 | $0 | 186,156 (Direct) |
View |
| 2021-03-30 Exercise |
2021-04-01 7:37 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $4.12 | 107,043 (Direct) |
View |
| 2021-03-30 Exercise |
2021-04-01 7:37 pm |
N/A 2028-04-09 |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
22,500 | $0 | 107,043 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-26 8:05 pm |
N/A 2031-03-25 |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A See Remarks |
104,997 | $0 | 203,563 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-26 8:03 pm |
N/A 2031-03-25 |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
325,000 | $0 | 1,252,630 (Direct) |
View |
| 2021-02-16 Gift |
2021-03-26 8:03 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
150,000 | $0 | 1,252,630 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-26 8:02 pm |
N/A 2031-03-25 |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
47,610 | $0 | 47,610 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-26 7:59 pm |
N/A 2031-03-25 |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
47,610 | $0 | 57,610 (Direct) |
View |
| 2021-03-11 Other |
2021-03-25 07:42 am |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Borisy Alexis Director |
28,538 | $0 | 262,713 (Direct) |
View |
| 2021-02-19 Other |
2021-02-19 8:00 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Borisy Alexis Director |
30,194 | $0 | 235,831 (Direct) |
View |
| 2021-02-05 Other |
2021-02-09 8:00 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Borisy Alexis Director |
70,956 | $0 | 246,399 (Direct) |
View |
| 2021-01-28 Exercise |
2021-01-29 9:00 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
5,000 | $4.12 | 176,786 (Direct) |
View |
| 2021-01-28 Exercise |
2021-01-29 9:00 pm |
N/A 2028-03-22 |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
5,000 | $0 | 176,786 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 4:30 pm |
N/A 2030-03-01 |
Relay Therapeutics Inc. | RLAY | Catinazzo Thomas Senior Vice President, Finance |
63,363 | $0 | 63,363 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 4:30 pm |
N/A 2030-03-01 |
Relay Therapeutics Inc. | RLAY | Bergstrom Donald A See Remarks |
126,727 | $0 | 126,727 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 4:30 pm |
N/A 2030-03-01 |
Relay Therapeutics Inc. | RLAY | Adams Brian General Counsel |
67,588 | $0 | 67,588 (Direct) |
View |
| 2020-12-11 Option Award |
2020-12-15 4:30 pm |
N/A 2030-03-01 |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
753,804 | $0 | 753,804 (Direct) |
View |
| 2020-07-20 Conversion |
2020-07-21 7:23 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
58,230,154 | $0 | 12,799,078 (Direct) |
View |
| 2020-07-20 Conversion |
2020-07-21 7:21 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | SVF Pauling (Cayman) Ltd SOFTBANK VISION FUND (AIV M2) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner |
126,993,255 | $0 | 27,904,963 (Indirect) |
View |
| 2020-07-20 Conversion |
2020-07-21 7:19 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Murcko Mark Director |
2,550,545 | $0 | 1,021,952 (Direct) |
View |
| 2020-07-20 Conversion |
2020-07-21 7:14 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Borisy Alexis Director |
475,514 | $0 | 104,487 (Direct) |
View |
| 2020-07-20 Conversion |
2020-07-21 5:34 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Picularium LLC SHAW DAVID E 10% Owner |
14,932,723 | $0 | 3,281,253 (Direct) |
View |
| 2020-07-20 Conversion |
2020-07-20 6:12 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Alexandria Venture Investments LLC 10% Owner |
4,406,964 | $0 | 968,365 (Direct) |
View |
Ownership |
2020-07-15 8:34 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Patel Sanjiv President and CEO |
0 | $0 | 2,994,014 (Direct) |
View |
Ownership |
2020-07-15 8:32 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Alexandria Venture Investments LLC 10% Owner |
0 | $0 | 968,365 (Direct) |
View |
Ownership |
2020-07-15 8:31 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | Third Rock Ventures III L.P. Third Rock Ventures GP III L.P. TRV GP III LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
0 | $0 | 13,362,312 (Direct) |
View |
Ownership |
2020-07-15 8:28 pm |
N/A N/A |
Relay Therapeutics Inc. | RLAY | SVF Pauling (Cayman) Ltd SOFTBANK VISION FUND (AIV M2) L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner |
0 | $0 | 27,904,963 (Indirect) |
View |